Ellis Rachel M, Koch Laine H, McGuire Erin, Williams Judith V
Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Pediatr Dermatol. 2011 May-Jun;28(3):242-4. doi: 10.1111/j.1525-1470.2011.01493.x.
This study sought to identify barriers to treatment in children with chronic inflammatory skin disease, particularly those with atopic dermatitis, psoriasis, and acne vulgaris. Caregivers of 101 patients seen in the Children's Specialty Group Division of Dermatology, Children's Hospital of The King's Daughters, Norfolk, Virginia, completed an 11-item Likert scale questionnaire. This survey addressed complexity and time requirements for treatment, medication cost, vehicle formulation, perceived safety, and caregiver understanding of chronicity of skin disorders. Parents and caregivers indicated that adequate instructions for using the medications were provided but that they felt less comfortable with treating their child's skin disease during a severe flare. The complexity of treatment programs, time required to apply medications, and vehicle type were not considered prohibitive factors. Caregivers were concerned about the cost and safety of prescribed medications and had a less understanding of the chronicity of inflammatory skin disorders.
本研究旨在确定慢性炎症性皮肤病患儿，尤其是特应性皮炎、银屑病和寻常痤疮患儿的治疗障碍。弗吉尼亚州诺福克市国王女儿儿童医院皮肤科儿童专科组的101名患者的护理人员完成了一份11项李克特量表问卷。该调查涉及治疗的复杂性和时间要求、药物成本、剂型、感知安全性以及护理人员对皮肤疾病慢性病程的理解。家长和护理人员表示，已获得使用药物的充分说明，但在严重发作期间治疗孩子的皮肤病时，他们感觉不太自在。治疗方案的复杂性、用药所需时间和剂型不被视为阻碍因素。护理人员担心处方药的成本和安全性，对炎症性皮肤病的慢性病程了解较少。
